204 related articles for article (PubMed ID: 36261663)
1. Preparation, physicochemical characterization, and bioactivity evaluation of berberine-entrapped albumin nanoparticles.
Younis FA; Saleh SR; El-Rahman SSA; Newairy AA; El-Demellawy MA; Ghareeb DA
Sci Rep; 2022 Oct; 12(1):17431. PubMed ID: 36261663
[TBL] [Abstract][Full Text] [Related]
2. In situ preparation of water-soluble ginsenoside Rh2-entrapped bovine serum albumin nanoparticles: in vitro cytocompatibility studies.
Singh P; Kim YJ; Singh H; Ahn S; Castro-Aceituno V; Yang DC
Int J Nanomedicine; 2017; 12():4073-4084. PubMed ID: 28603419
[TBL] [Abstract][Full Text] [Related]
3. Dual-functional Brij-S20-modified nanocrystal formulation enhances the intestinal transport and oral bioavailability of berberine.
Xiong W; Sang W; Linghu KG; Zhong ZF; Cheang WS; Li J; Hu YJ; Yu H; Wang YT
Int J Nanomedicine; 2018; 13():3781-3793. PubMed ID: 29988733
[TBL] [Abstract][Full Text] [Related]
4. Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles.
Xue M; Yang MX; Zhang W; Li XM; Gao DH; Ou ZM; Li ZP; Liu SH; Li XJ; Yang SY
Int J Nanomedicine; 2013; 8():4677-87. PubMed ID: 24353417
[TBL] [Abstract][Full Text] [Related]
5. The inhibitory effect of PLGA-encapsulated berberine on hepatotoxicity and α-smooth muscle actin (α-SMA) gene expression.
Ahrari A; Najafzadehvarzi H; Taravati A; Tohidi F
Life Sci; 2021 Nov; 284():119884. PubMed ID: 34389401
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR's cholesterol-decreasing efficacy in patients.
Wu C; Zhao Y; Zhang Y; Yang Y; Su W; Yang Y; Sun L; Zhang F; Yu J; Wang Y; Guo P; Zhu B; Wu S
J Adv Res; 2022 Mar; 37():197-208. PubMed ID: 35499044
[TBL] [Abstract][Full Text] [Related]
7. Berberine Nanoencapsulation Attenuates Hallmarks of Scoplomine Induced Alzheimer's-Like Disease in Rats.
Saleh SR; Abady MM; Nofal M; Yassa NW; Abdel-Latif MS; Nounou MI; Ghareeb DA; Abdel-Monaem N
Curr Rev Clin Exp Pharmacol; 2021; 16(2):139-154. PubMed ID: 32598269
[TBL] [Abstract][Full Text] [Related]
8. Combined ROS Responsive Polydopamine-Coated Berberine Nanoparticles Effective Against Ulcerative Colitis in Mouse Model.
Chang C; Liu H; Li X; Song D; Liu Y; Lu C; Zhen Y; Chen Y; Xu J; Li W; Jia X; Chen Z; Chen R
Int J Nanomedicine; 2024; 19():1205-1224. PubMed ID: 38348171
[TBL] [Abstract][Full Text] [Related]
9. Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: Part 1. Physicochemical and pharmacokinetic properties.
Murakami T; Bodor E; Bodor N
Expert Opin Drug Metab Toxicol; 2023 Mar; 19(3):129-137. PubMed ID: 37057922
[TBL] [Abstract][Full Text] [Related]
10. In vivo anti-apoptosis activity of novel berberine-loaded chitosan nanoparticles effectively ameliorates osteoarthritis.
Zhou Y; Liu SQ; Peng H; Yu L; He B; Zhao Q
Int Immunopharmacol; 2015 Sep; 28(1):34-43. PubMed ID: 26002585
[TBL] [Abstract][Full Text] [Related]
11. Development and In Vitro Evaluation of Linear PEI-Shelled Heparin/Berberine Nanoparticles in Human Osteosarcoma U-2 OS Cells.
Hsu HK; Hsu KH; Cheng YM; Suen HY; Peng SF
Molecules; 2018 Nov; 23(12):. PubMed ID: 30487471
[TBL] [Abstract][Full Text] [Related]
12. Berberine inhibits palmitate-induced NLRP3 inflammasome activation by triggering autophagy in macrophages: A new mechanism linking berberine to insulin resistance improvement.
Zhou H; Feng L; Xu F; Sun Y; Ma Y; Zhang X; Liu H; Xu G; Wu X; Shen Y; Sun Y; Wu X; Xu Q
Biomed Pharmacother; 2017 May; 89():864-874. PubMed ID: 28282788
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of surface-modified berberine nanoparticles against LPS-induced neurodegenerative changes: a preclinical study.
Soudi SA; Nounou MI; Sheweita SA; Ghareeb DA; Younis LK; El-Khordagui LK
Drug Deliv Transl Res; 2019 Oct; 9(5):906-919. PubMed ID: 30868509
[TBL] [Abstract][Full Text] [Related]
14. Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: part 2. development of oral dosage formulations.
Murakami T; Bodor E; Bodor N
Expert Opin Drug Metab Toxicol; 2023 Mar; 19(3):139-148. PubMed ID: 37060323
[TBL] [Abstract][Full Text] [Related]
15. PEG-lipid-PLGA hybrid nanoparticles loaded with berberine-phospholipid complex to facilitate the oral delivery efficiency.
Yu F; Ao M; Zheng X; Li N; Xia J; Li Y; Li D; Hou Z; Qi Z; Chen XD
Drug Deliv; 2017 Nov; 24(1):825-833. PubMed ID: 28509588
[TBL] [Abstract][Full Text] [Related]
16. O-hexadecyl-dextran entrapped berberine nanoparticles abrogate high glucose stress induced apoptosis in primary rat hepatocytes.
Kapoor R; Singh S; Tripathi M; Bhatnagar P; Kakkar P; Gupta KC
PLoS One; 2014; 9(2):e89124. PubMed ID: 24586539
[TBL] [Abstract][Full Text] [Related]
17. Self-nanoemulsifying system improves oral absorption and enhances anti-acute myeloid leukemia activity of berberine.
Li J; Yang L; Shen R; Gong L; Tian Z; Qiu H; Shi Z; Gao L; Sun H; Zhang G
J Nanobiotechnology; 2018 Oct; 16(1):76. PubMed ID: 30290822
[TBL] [Abstract][Full Text] [Related]
18. Nanoformulation and Evaluation of Oral Berberine-Loaded Liposomes.
Duong TT; Isomäki A; Paaver U; Laidmäe I; Tõnisoo A; Yen TTH; Kogermann K; Raal A; Heinämäki J; Pham TM
Molecules; 2021 Apr; 26(9):. PubMed ID: 33946815
[TBL] [Abstract][Full Text] [Related]
19. Berberine-loaded liposomes for oral delivery: Preparation, physicochemical characterization and in-vivo evaluation in an endogenous hyperlipidemic animal model.
Duong TT; Yen TTH; Nguyen LT; Nguyen TD; Nguyen TQ; Nghiem TH; Pham HT; Raal A; Heinämäki J; Pham TM
Int J Pharm; 2022 Mar; 616():121525. PubMed ID: 35104597
[TBL] [Abstract][Full Text] [Related]
20. Berberine alleviates nonalcoholic fatty liver induced by a high-fat diet in mice by activating SIRT3.
Xu X; Zhu XP; Bai JY; Xia P; Li Y; Lu Y; Li XY; Gao X
FASEB J; 2019 Jun; 33(6):7289-7300. PubMed ID: 30848932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
